Patient-Customized Oligonucleotide Therapy for a Rare Genetic DiseaseJin‐Kuk Kim, Timothy W. Yu, Aubrie Soucy et al.|New England Journal of Medicine|2019Cited by 808
GSTM1 null genotype underpins recurrence of NF2 meningiomasAnthony C. Johnson, Ian F. Dunn, Erdyni N. Tsitsikov et al.|Frontiers in Oncology|2024Cited by 1
TRAF7 in signaling and disease: emerging mechanisms and clinical implicationsAlbert Orock, Ian F. Dunn, Jeffrey Zuccato et al.|Molecular Medicine|2025Cited by 1
Spontaneous Mutation in <i>2310061I04Rik</i> Results in Reduced Expression of Mitochondrial Genes and Impaired Brain MyelinationErdyni N. Tsitsikov, Ian F. Dunn, Khanh P. Phan et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 0
Spontaneous mutation in 2310061I04Rik results in reduced expression of mitochondrial genes and impaired brain myelinationErdyni N. Tsitsikov, Ian F. Dunn, Khanh P. Phan et al.|PLoS ONE|2024Cited by 0